Decreased P-glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells

Bioelectromagnetics

Volumn 35, Issue 6, 2014, Pages 437-443

  Zhang, Kun ^a   Chen, Wenfang ^a,b   Bu, Ting ^a,c   Qi, Hao ^a   Sun, Runguang ^a   He, Xiao ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b National Engineering Research Center for Miniaturized Detection System   (China)

^c Provincial Key University Laboratory for Protection and Utilization of Long Dong Bio Resources   (China)

Author keywords

K562 cell; Metabolic activity; P glycoprotein, cisplatin; Static magnetic field

Indexed keywords

CYTOLOGY; GLYCOPROTEINS; MAGNETIC FIELD EFFECTS; METABOLISM;

CELL/B.E; CIS-PLATIN; CISPLATIN; EXTRACELLULAR; INHIBITORY EFFECT; K562 CELLS; METABOLIC ACTIVITY; P-GLYCOPROTEIN; P-GLYCOPROTEIN, CISPLATIN; STATIC MAGNETIC FIELDS;

CELLS;

CISPLATIN; MULTIDRUG RESISTANCE PROTEIN; RADIOSENSITIZING AGENT;

DRUG EFFECTS; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACELLULAR SPACE; K562 CELL LINE; MAGNETIC FIELD; METABOLISM; RADIATION RESPONSE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HUMANS; INTRACELLULAR SPACE; K562 CELLS; MAGNETIC FIELDS; P-GLYCOPROTEIN; RADIATION-SENSITIZING AGENTS;

EID: 84906088666     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.21863     Document Type: Article

References (34)

1. Andrews PA, Wung WE, Howell SB. 1984. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate. Anal Biochem 143:46-56.
2. Bannister SJ, Sternson LA, Repta AJ. 1979. Urine analysis of platinum species derived from cis-dichlorodiammineplatinum (II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate. J Chromatogr 173:333-342.
3. 2+ influx and ROS production. Int J Cardiol 167:798-808.
4. Bell DN, Liu JJ, Tingle MD, McKeage MJ. 2006. Specific determination of intact cisplatin and monohydrated cisplatin in human plasma and culture medium ultrafiltrates using HPLC on-line with inductively coupled plasma mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 837:29-34.
5. Brix G, Strieth S, Strelczyk D, Dellian M, Griebel J, Eichhorn ME, Andra W, Bellemann ME. 2008. Static magnetic fields affect capillary flow of red blood cells in striated skin muscle. Microcirculation 15:15-26.
6. Callaghan R, Crowley E, Potter S, Kerr ID. 2008. P-glycoprotein: So many ways to turn it on. J Clin Pharmacol 48:365-378.
7. Chen WF, Qi H, Sun RG, Liu Y, Zhang K, Liu JQ. 2010. Static magnetic fields enhanced the potency of cisplatin on k562 cells. Cancer Biother Radiopharm 25:401-408.
8. Chionna A, Dwikat M, Panzarini E, Tenuzzo B, Carla EC, Verri T, Pagliara P, Abbro L, Dini L. 2003. Cell shape and plasma membrane alterations after static magnetic fields exposure. Eur J Histochem 47:299-308.
9. Chionna A, Tenuzzo B, Panzarini E, Dwikat MB, Abbro L, Dini L. 2005. Time dependent modifications of Hep G2 cells during exposure to static magnetic fields. Bioelectromagnetics 26:275-286.
10. Dini L, Abbro L. 2005. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 36:195-217.
11. El-Yazigi A, Al-Saleh I. 1986. Rapid determination of platinum by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients. Ther Drug Monit 8:318-320.
12. Eveson RW, Timmel CR, Brocklehurst B, Hore PJ, McLauchlan KA. 2000. The effects of weak magnetic fields on radical recombination reactions in micelles. Int J Radiat Biol 76:1509-1522.
13. Gellrich D, Becker S, Strieth S. 2014. Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel. Cancer Letters 343:107-114.
14. Gray JR, Frith CH, Parker JD. 2000. In vivo enhancement of chemotherapy with static electric or magnetic fields. Bioelectromagnetics 21:575-583.
15. Hamada H, Tsuruo T. 1988. Characterization of the ATPase activity of the Mr 170, 000 to 180, 000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res 48:4926-4932.
16. Hopfer SM, Ziebka L, Sunderman FW Jr, Sporn JR, Greenberg BR. 1989. Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry. Ann Clin Lab Sci 19:389-396.
17. Hsu SH, Chang JC. 2010. The static magnetic field accelerates the osteogenic differentiation and mineralization of dental pulp cells. Cytotechnology 62:143-155.
18. Jung Y, Lippard SJ. 2007. Direct cellular responses to platinum-induced DNA damage. Chem Rev 107:1387-1407.
19. Juranka PF, Zastawny RL, Ling V. 1989. P-glycoprotein: Multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J 3:2583-2592.
20. Lopez-Flores A, Jurado R, Garcia-Lopez P. 2005. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples. J Pharmacol Toxicol Methods 52:366-372.
21. Qi H, Chen WF, Ai X, Wei Q, Liu Y, Zhang K, Sun RG. 2011. Effects of moderate-intensity static magnetic fields and adriamycin on K562 cells. Bioelectromagnetics 32:191-199.
22. Pera MF Jr, Harder HC. 1977. Analysis for platinum in biological material by flameless atomic absorption spectrometry. Clin Chem 23:1245-1249.
23. Raylman RR, Clavo AC, Wahl RL. 1996. Exposure to strong static magnetic field slows the growth of human cancer cells in vitro. Bioelectromagnetics 17:358-363.
24. Sabo J, Mirossay L, Horovcak L, Sarissky M, Mirossay A, Mojzis J. 2002. Effects of static magnetic field on human leukemic cell line HL-60. Bioelectrochemistry 56:227-231.
25. Su L, Mruk DD, Lui WY, Lee WM, Cheng CY. 2011. P-glycoprotein regulates blood-testis barrier dynamics via its effects on the occludin/zonula occludens 1 (ZO-1) protein complex mediated by focal adhesion kinase (FAK). Proc Natl Acad Sci USA 108:19623-19628.
26. Sun RG, Chen WF, Qi H, Zhang K, Bu T, Liu Y, Wang SR. 2012. Biologic effects of SMF and paclitaxel on K562 human leukemia cells. Gen Physiol Biophys 31:1-10.
27. Tenuzzo B, Chionna A, Panzarini E, Lanubile R, Tarantino P, Di Jeso B, Dwikat M, Dini L. 2006. Biological effects of 6mT static magnetic fields: A comparative study in different cell types. Bioelectromagnetics 27:560-577.
28. Tofani S, Barone D, Berardelli M, Berno E, Cintorino M, Foglia L, Ossola P, Ronchetto F, Toso E, Eandi M. 2003. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cisplatin against Lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol Res 48:83-90.
29. Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R, Silvestrini R. 1994. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer 30A:1002-1007.
30. Volckova E, Dudones LP, Bose RN. 2002. HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: Implications of dominant platinum-thiol binding to its anticancer action. Pharm Res 19:124-131.
31. Wolf FI, Torsello A, Tedesco B, Fasanella S, Boninsegna A, D'Ascenzo M, Grassi C, Azzena GB, Cittadini A. 2005. 50Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: Possible involvement of a redox mechanism. Biochim Biophys Acta 1743:120-129.
32. Xu HB, Li L, Liu GQ. 2009. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Pharmazie 64:660-665.
33. Yang X, Page M. 1995. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin. Oncol Res 7:619-624.
34. Yang JC, Lee SY, Chen CA, Lin CT, Chen CC, Huang HM. 2010. The role of the calmodulin-dependent pathway in static magnetic field-induced mechanotransduction. Bioelectromagnetics 31:255-261.